Summary of Oshkosh Corporation 2026 Conference Call Company Overview - **Company**: Oshkosh Corporation (NYSE: OSK) - **Industry**: Industrial Technology - **2026 Revenue Guidance**: Approximately $11 billion - **Segments**: - **Access Segment**: Construction equipment, projected revenue of $4.2 billion - **Vocational Segment**: Equipment for neighborhoods (fire trucks, refuse equipment), projected revenue of $4.2 billion - **Transport Segment**: Defense vehicles and delivery vehicles, projected revenue of $2.5 billion [4][5][6] Core Insights and Arguments - **Segment Growth**: The vocational segment has shown significant growth, particularly after the acquisition of airport products in 2023. The transport segment is expected to improve margins from 4% in 2026 to 10% by 2028 due to new contracts with the Department of Defense [6][6]. - **Technological Advancements**: Emphasis on electrification, connectivity, robotics, autonomy, and AI across all segments. The company aims to leverage technology to enhance productivity and differentiate its products [11][12][15]. - **Market Positioning**: JLG and SkyTrak brands are positioned strongly in the AWP and telehandler space, focusing on quality, reliability, and strong residual value, which is crucial for rental companies [20][21]. - **Access Segment Outlook**: Despite a weak non-residential construction sector, large projects and national contractors are expected to drive growth. The company remains optimistic about the access segment's performance in 2026 and beyond [28][30]. - **Vocational Segment Dynamics**: The fire apparatus segment is experiencing a backlog extending into 2028, with a focus on increasing production capacity by 25%-30%. The refuse segment is currently facing a pause in new contracts due to municipalities hesitating to lock in long-term contracts at peak pricing [37][40][42]. - **Transport Segment Challenges**: The Next Generation Delivery Vehicle (NGDV) production ramp has been slower than anticipated, with current production at the lower end of the capacity range (16,000 units). The company is taking a methodical approach to improve production efficiency [72][73][85]. Additional Important Points - **Margin Improvement Strategy**: The transport segment aims to increase its operating income margin from 4% to 10% by 2028 through new contracts and improved production efficiency [85][89]. - **Capital Allocation**: The company prioritizes maintaining a healthy balance sheet, funding business growth, and returning cash to shareholders through dividends and share repurchases. An 11% increase in dividends was announced for the year [125][126]. - **M&A Strategy**: Oshkosh is focused on bolt-on acquisitions to support existing businesses, with a pipeline for potential acquisitions [126][127]. This summary encapsulates the key points discussed during the Oshkosh Corporation conference call, highlighting the company's strategic direction, market positioning, and financial outlook.

Core Viewpoint - The company focuses on four core technology areas: sensing, AI computing, connectivity, and security, providing differentiated products and services for smart terminals, IoT, and automotive electronics [1] Product Offerings - Main products include fingerprint recognition, touch control, audio, NFC/eSE/eSIM, optical sensing, health, and Bluetooth chips and solutions [1] - Storage chips are not part of the company's product range [1]

（文章来源：证券日报） 证券日报网讯 1月22日，福莱新材在互动平台回答投资者提问时表示，公司已积累多条传感技术路线， 在相关方向上具备技术专家团队与专利储备；这些不同的传感路线也都已在传感器产品中得到实际应用 与验证。公司会基于客户需求与产品需求等综合因素进行评估与选择，匹配最适合的技术方案并推进落 地。 ...

Core Viewpoint - Top Cloud Agriculture's integrated sensing and monitoring system utilizes core technologies based on sensing technology and the Internet of Things (IoT) for real-time remote monitoring of agricultural information [2] Group 1: Technology Overview - The system collects data through various sensors to monitor critical information related to climate, soil, and plant health that affects crop growth [2] - The application of satellite and remote sensing technology is also involved in this monitoring system [2]

Core Viewpoint - The research on nanorobots for cancer treatment is advancing, with significant improvements in their ability to deliver drugs precisely to targeted areas within the body, potentially revolutionizing cancer diagnosis, monitoring, and treatment methods [2][3]. Group 1: Nanorobots Research - The team led by Sylvain Martel at the Montreal Institute of Technology has spent over a decade developing nanorobots that can be controlled using MRI technology to deliver cancer drugs directly to tumors [2][3]. - Recent experiments showed that by adjusting the position of pigs in MRI machines, the number of nanorobots reaching the liver increased by nearly three times compared to previous tests [2]. - The research indicates that the technology is nearing practical application in humans, which could lead to innovative methods for cancer treatment, including targeted drug delivery and tumor monitoring [3]. Group 2: Publication and Future Directions - The findings are published in a recent issue of Nature Focus, which explores the application of nanorobots in cancer treatment and other advanced robotics topics [4]. - Future editions of Nature Focus will cover rapidly developing topics in various fields, including robotics and AI, indicating a growing interest and investment in these technologies [5].

Core Viewpoint - The company is actively engaging in the humanoid robot sector, focusing on innovation and product development to meet market trends and customer demands [1] Company Summary - The company has established partnerships with clients in the robotics field and their component manufacturers [1] - It is committed to providing competitive products and solutions for target market customers [1] - The company specializes in high-end equipment manufacturing, particularly in CNC machine tools [1] Industry Summary - Humanoid robots integrate advanced technologies such as artificial intelligence, high-end manufacturing, precision machinery, and sensing technology, positioning them as key drivers of future industrial transformation and social services [1] - Major global tech companies like Tesla and Amazon are increasing investments in humanoid robots, while domestic initiatives are promoting the "robot+" application, indicating a shift from experimental to commercial applications in the humanoid robot industry [1] - The humanoid robot industry presents significant market potential, attracting attention from upstream and downstream enterprises within the industry chain [1] - The company’s products, including drilling and milling centers, vertical machining centers, and five-axis machining centers, are suitable for precision processing of core components in humanoid robots [1] - The company aims to leverage its expertise in precision manufacturing to penetrate the high-growth, high-value humanoid robot industry chain [1]

Core Insights - Hanwang Technology launched the KSY3610 and KSY8600 electronic blood pressure monitors, emphasizing affordability and advanced features like atrial fibrillation screening [1][2] - The KSY3610 is priced starting at 259 yuan, aiming to make high-end blood pressure monitoring technology accessible to a broader market [1][2] - The company promotes a "technology for all" philosophy, seeking to provide high-quality health monitoring devices at reasonable prices [1][2] Product Features - The KSY3610 combines the measurement precision of traditional mercury sphygmomanometers with the convenience of electronic devices [2] - It is the only electronic blood pressure monitor in its price range that integrates with the Hanwang Health APP, allowing real-time data synchronization and comprehensive health reporting [2] - The device features an AI-driven health management model, enabling users to ask health-related questions and receive professional answers [2] Market Context - The prevalence of hypertension in China is rising, with a reported rate of 25.2% among individuals aged 18 and older, translating to approximately 270 million patients [2] - This growing patient population presents significant market opportunities for blood pressure monitoring devices [2] Business Strategy - Hanwang's strategy of offering high-functionality products at low prices is expected to rapidly increase market share and brand recognition [3] - While individual product profit margins may decrease, the company anticipates substantial commercial returns through economies of scale and enhanced service value [3] - The introduction of affordable, high-precision health monitoring devices is likely to improve awareness, treatment rates, and control rates of chronic diseases like hypertension [3]

Group 1 - EssilorLuxottica, the world's largest eyewear manufacturer, reported that sales of the Ray-Ban Meta smart glasses increased more than twofold, contributing to total sales of €14.02 billion (approximately $16.25 billion) in the first half of the year, a year-on-year increase of 7.3% [1] - The CEO Francesco Milleri and Deputy CEO Paul du Saillant stated that the company is leading the transformation of eyewear as the next generation computing platform, integrating AI, sensing technology, and data-rich healthcare facilities [1] - The new Oakley Meta smart glasses, launched in June, are part of the latest product line developed in collaboration with Meta, with plans for a Prada-branded smart glasses in the future [1] Group 2 - EssilorLuxottica owns several well-known brands, including Ray-Ban, Oakley, Vogue Eyewear, and Persol [2] - Meta and EssilorLuxottica have signed a long-term cooperation agreement to develop multiple generations of smart eyewear products over the next decade [2] - Meta has acquired just under 3% of EssilorLuxottica's shares, valued at approximately €3 billion ($3.5 billion), and is considering increasing its stake to around 5% [2]

Core Insights - EssilorLuxottica reported strong performance in its smart glasses segment, particularly with the Ray-Ban Meta smart glasses, which saw sales more than double year-over-year [3][4] - The company's total sales for the first half of the year reached €14.02 billion (approximately $16.25 billion), reflecting a 7.3% increase compared to the same period last year [3] - The collaboration with Meta, initiated in 2019, has positioned EssilorLuxottica as a leader in transforming the eyewear industry into a new computing platform that integrates AI, sensing technology, and healthcare data [3] Product Development - In June, EssilorLuxottica launched the new Oakley Meta smart glasses, marking the latest addition to its product line developed in partnership with Meta [4] - There are plans for a Prada-branded smart glasses product, which has garnered significant market attention [4] - The renewal of the long-term partnership agreement between Meta and Luxottica for the next decade aims to develop multiple generations of smart glasses, indicating strong confidence in the smart glasses market [4] Market Outlook - The ongoing collaboration between EssilorLuxottica and Meta, along with advancements in smart eyewear technology, is expected to drive market growth and enhance consumer experiences with innovative products [4]

Group 1: Industry Overview - Brain-computer interface (BCI) technology is advancing rapidly due to breakthroughs in artificial intelligence, neuroscience, and sensing technologies [1] - The Sichuan Provincial Economic and Information Technology Department has launched a plan to develop BCI products, aiming to complete the R&D of 3 invasive and 5 non-invasive BCI products by 2027 [1] - The plan also targets to serve over 50,000 medical patients annually by 2027 and to establish Sichuan as a national leader in BCI and human-computer interaction by 2030 [1] Group 2: Non-Invasive BCI Applications - Non-invasive BCI technology is expected to significantly improve the early diagnosis and treatment efficiency of Alzheimer's disease [2] - The technology aims to manage chronic diseases in the elderly through early screening and outpatient rehabilitation [2] - A project named "Swan Lake" has been developed for community-based early screening and non-drug interventions for mild cognitive impairment (MCI) [2][3] Group 3: Research Findings - Research involving over 3,000 elderly participants has shown that MCI patients exhibit abnormal frequency bands and network patterns [3] - Non-invasive BCI screening can achieve over 90% sensitivity using just 4 electrodes in a 5-10 minute test, enhancing the efficiency of MCI screening [3] - Non-invasive BCI techniques like transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (TES) are being explored for outpatient rehabilitation of MCI [3] Group 4: Invasive BCI Innovations - Invasive BCI technology has achieved a breakthrough in the surgical treatment of gliomas, marking a significant advancement in neurosurgery [5][6] - The technology allows for real-time analysis of brain signals to differentiate tumor tissue from normal brain tissue, improving tumor resection rates [6] - The first successful application of invasive BCI technology for glioma surgery in China has been reported, showcasing its potential to enhance surgical outcomes [6][7] Group 5: Future Prospects - Invasive BCI technology not only maximizes safe tumor removal but also predicts tumor recurrence, potentially extending patient survival [7] - The industry is awaiting the development of mature products and technologies that could lead to transformative changes in medical practices [7]